Measurement of nutrition status in crohn's disease patients receiving infliximab therapy

Nutrition in Clinical Practice

Volumn 23, Issue 5, 2008, Pages 551-556

  Wiese, Dawn ^a   Lashner, Bret ^b   Seidner, Douglas ^b  

^a CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Body composition; Crohn's disease; Infliximab; Nutrition assessment

Indexed keywords

BETA CAROTENE; C REACTIVE PROTEIN; CITRULLINE; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE THIOLACTONE; INFLIXIMAB; VITAMIN D; XYLOSE; ANTIINFLAMMATORY AGENT; MONOCLONAL ANTIBODY;

ADULT; ARTICLE; BODY COMPOSITION; BODY MASS; CARBOHYDRATE ABSORPTION; CELL FUNCTION; CLINICAL ARTICLE; COLON CROHN DISEASE; CONTROLLED STUDY; DISEASE ACTIVITY; ENERGY EXPENDITURE; FAT BODY; FEMALE; FOLIC ACID BLOOD LEVEL; FOOD INTAKE; HUMAN; INTESTINE CELL; LEAN BODY WEIGHT; LIPOLYSIS; MAINTENANCE THERAPY; MALE; METABOLISM; MUSCLE MASS; NUTRITIONAL STATUS; PATIENT ASSESSMENT; QUESTIONNAIRE; RESPIRATORY QUOTIENT; STARVATION; TREATMENT DURATION; WEIGHT GAIN; BASAL METABOLIC RATE; BLOOD; CROHN DISEASE; HOSPITALIZATION; MIDDLE AGED; OXYGEN CONSUMPTION; PHYSIOLOGY;

ADULT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; BASAL METABOLISM; BODY COMPOSITION; CROHN DISEASE; ENTEROCYTES; FEMALE; FOLIC ACID; HUMANS; MALE; MIDDLE AGED; NUTRITIONAL STATUS; OXYGEN CONSUMPTION; SEVERITY OF ILLNESS INDEX;

EID: 55949127360     PISSN: 08845336     EISSN: None     Source Type: Journal    
DOI: 10.1177/0884533608323421     Document Type: Article

References (35)

1. Geerling BJ, Badart-Smook A., Stockbrugger RW, Brummer RJ Comprehensive nutritional status in recently diagnosed patients with inflammatory bowel disease compared with population controls. Eur J Clin Nutr. 2000 ; 54: 514-521.
2. Schneeweiss B., Lochs H., Zauner C., et al. Energy and substrate metabolism in patients with active Crohn's disease. J Nutr. 1999 ; 129: 844-848.
3. Al-Jaouni R., Hebuterne X., Pouget I., Rampal P. Energy metabolism and substrate oxidation in patients with Crohn's disease. Nutrition. 2000 ; 16: 173-178.
4. Kushner RF, Schoeller DA Resting and total energy expenditure in patients with inflammatory bowel disease. Am J Clin Nutr. 1991 ; 53: 161-165.
5. Kuroki F., Iida M., Tominaga M., et al. Multiple vitamin status in Crohn's disease. Correlation with disease activity. Dig Dis Sci. 1993 ; 38: 1614-1618.
6. Geerling BJ, Badart-Smook A., Stockbrugger RW, Brummer RJ Comprehensive nutritional status in patients with long-standing Crohn disease currently in remission. Am J Clin Nutr. 1998 ; 67: 919-926.
7. Lanfranchi GA, Brignola C., Campieri M., et al. Assessment of nutritional status in Crohn's disease in remission or low activity. Hepatogastroenterology. 1984 ; 31: 129-132.
8. Goh J., O'Morain CA Review article: nutrition and adult inflammatory bowel disease. Aliment Pharmacol Ther. 2003 ; 17: 307-320.
9. Cohen RD, Tsang JF, Hanauer SB Infliximab in Crohn's disease: first anniversary clinical experience. Am J Gastroenterol. 2000 ; 95: 3469-3477.
10. Hanauer SB, Feagan BG, Lichtenstein GR, et al. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet. 2002 ; 359: 1541-1549.
11. Guyatt G., Mitchell A., Irvine EJ, et al. A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology. 1989 ; 96: 804-810. (Pubitemid 19057603)
12. Harvey RF, Bradshaw JM A simple index of Crohn's-disease activity. Lancet. 1980 ; 1: 514.
13. Crenn P., Vahedi K., Lavergne-Slove A., Cynober L., Matuchansky C., Messing B. Plasma citrulline: a marker of enterocyte mass in villous atrophy-associated small bowel disease. Gastroenterology. 2003 ; 124: 1210-1219.
14. Papadia C., Sherwood RA, Kalantzis C., et al. Plasma citrulline concentration: a reliable marker of small bowel absorptive capacity independent of intestinal inflammation. Am J Gastroenterol. 2007 ; 102: 1474-1482.
15. Crenn P., Coudray-Lucas C., Thuillier F., Cynober L., Messing B. Postabsorptive plasma citrulline concentration is a marker of absorptive enterocyte mass and intestinal failure in humans. Gastroenterology. 2000 ; 119: 1496-1505.
16. Ingenbleek Y., Carpentier YA A prognostic inflammatory and nutritional index scoring critically ill patients. Int J Vitam Nutr Res. 1985 ; 55: 91-101.
17. Charney P. Nutrition assessment in the 1990s: where are we now? Nutr Clin Pract. 1995 ; 10: 131-139.
18. Schlossmacher P., Hasselmann M., Meyer N., et al. The prognostic value of nutritional and inflammatory indices in critically ill patients with acute respiratory failure. Clin Chem Lab Med. 2002 ; 40: 1339-1343.
19. Bonnefoy M., Ayzac L., Ingenbleek Y., Kostka T., Boisson RC, Bienvenu J. Usefulness of the prognostic inflammatory and nutritional index (PINI) in hospitalized elderly patients. Int J Vitam Nutr Res. 1998 ; 68: 189-195.
20. Terrier N., Senecal L., Dupuy AM, et al. Association between novel indices of malnutrition-inflammation complex syndrome and cardiovascular disease in hemodialysis patients. Hemodial Int. 2005 ; 9: 159-168.
21. Nelson KA, Walsh D. The cancer anorexia-cachexia syndrome: a survey of the Prognostic Inflammatory and Nutritional Index (PINI) in advanced disease. J Pain Symptom Manage. 2002 ; 24: 424-428.
22. Walsh D., Mahmoud F., Barna B. Assessment of nutritional status and prognosis in advanced cancer: interleukin-6, C-reactive protein, and the prognostic and inflammatory nutritional index. Support Care Cancer. 2003 ; 11: 60-62.
23. Franklin JL, Rosenberg HH Impaired folic acid absorption in inflammatory bowel disease: effects of salicylazosulfapyridine (Azulfidine). Gastroenterology. 1973 ; 64: 517-525.
24. Chowers Y., Sela BA, Holland R., Fidder H., Simoni FB, Bar-Meir S. Increased levels of homocysteine in patients with Crohn's disease are related to folate levels. Am J Gastroenterol. 2000 ; 95: 3498-3502.
25. Pohl C., Hombach A., Kruis W. Chronic inflammatory bowel disease and cancer. Hepatogastroenterology. 2000 ; 47: 57-70.
26. Gasche C., Lomer MC, Cavill I., Weiss G. Iron, anaemia, and inflammatory bowel diseases. Gut. 2004 ; 53: 1190-1197.
27. Keys A., Brozek J., Henschel A., Mickelson O., Taylor H. Biology of Human Starvation. Minneapolis, MN: University of Minnesota Press ; 1950.
28. Matarese LE, Steiger E., Seidner DL, Richmond B. Body composition changes in cachectic patients receiving home parenteral nutrition. JPEN. J Parenter Enteral Nutr. 2002 ; 26: 366-371.
29. Zahorska-Markiewicz B., Janowska J., Olszanecka-Glinianowicz M., Zurakowski A. Serum concentrations of TNF-alpha and soluble TNF-alpha receptors in obesity. Int J Obes Relat Metab Disord. 2000 ; 24: 1392-1395.
30. Simpson EJ, Chapman MA, Dawson J., Berry D., Macdonald IA, Cole A. In vivo measurement of colonic butyrate metabolism in patients with quiescent ulcerative colitis. Gut. 2000 ; 46: 73-77.
31. Winter TA, O'Keefe SJ, Callanan M., Marks T. The effect of severe undernutrition and subsequent refeeding on whole-body metabolism and protein synthesis in human subjects. JPEN. J Parenter Enteral Nutr. 2005 ; 29: 221-228.
32. Goodman MN Tumor necrosis factor induces skeletal muscle protein breakdown in rats. Am J Physiol. 1991 ; 260: E727 - E730.
33. Steiner SJ, Pfefferkorn MD, Fitzgerald JF, Denne SC Protein and energy metabolism response to the initial dose of infliximab in children with Crohn's disease. Inflamm Bowel Dis. 2007 ; 13: 737-744.
34. Van der Poll T., Romijn JA, Endert E., Borm JJ, Buller HR, Sauerwein HP Tumor necrosis factor mimics the metabolic response to acute infection in healthy humans. Am J Physiol. 1991 ; 261: E457 - E465.
35. Johnstone AM, Murison SD, Duncan JS, Rance KA, Speakman JR Factors influencing variation in basal metabolic rate include fat-free mass, fat mass, age, and circulating thyroxine but not sex, circulating leptin, or triiodothyronine. Am J Clin Nutr. 2005 ; 82: 941-948.